- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04423614
Preoperative Inspiratory Muscle Training
Telehealth-Delivered Preoperative Inspiratory Muscle Training: An Innovative Solution to Conserve Scarce ICU Resources
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Highly active muscles such as the diaphragm are particularly sensitive to both disuse and training. For example, diaphragm fibers of controlled mechanically ventilated young adults atrophy by more than 50% within 36 hours of complete inactivity, and mechanical ventilation (MV) initiates signaling pathways within the first several hours of inactivity that promote progressive diaphragmatic fiber dysfunction. The investigators have shown that widespread atrophy signaling begins in the operating room during cardiac surgery, after only a few hours of MV. In addition to this fiber atrophy, MV leads to significant declines in the strength of the diaphragm, which can lengthen the time it takes to wean from MV. The clinical occurrence of early onset, progressive contractile dysfunction is defined as ventilator-induced diaphragmatic dysfunction (VIDD). VIDD is regarded as a primary contributor to difficulties with weaning from MV.
Conversely, the investigators have shown that IMT increases the pressure-generating capacity of the diaphragm and inspiratory synergist muscles, and facilitates weaning in patients with VIDD. Preoperative IMT for as little as 1-2 weeks reportedly increases inspiratory muscle strength. IMT prior to cardiothoracic surgery has been shown to reduce post-operative pulmonary complications such as atelectasis, pneumonia, or delayed ventilator weaning. Additionally, strength gains associated with preoperative IMT are associated with shorter ICU and hospital lengths of stay, which may potentially offer a cost benefit.
Unfortunately, very little is understood about the neuromuscular adaptations and signaling mechanisms that contribute to these IMT clinical advantages. A particularly novel aspect of this project is it will be the first study of the mechanisms that contribute to diaphragm strengthening. A greater understanding of these mechanisms may help future investigators to develop more efficient exercise prescriptions to offset MV use in cases such as surgery, and it may help identify molecules and exercise that could protect the diaphragms of individuals who cannot exercise in advance, as in the case of acute infections that compromise breathing.
The overall objective of this study is to investigate diaphragm neuromuscular remodeling associated with pre-operative, telehealth delivered IMT, compared with relaxation breathing training (RLX). Guided RLX exercises have been shown to improve post-operative pain perception and modestly lower systolic blood pressure in hypertensives but are not thought to significantly alter diaphragm strength.
Forty adult volunteers will receive either IMT (n=20) or RLX training (n=20) for 2-4 weeks prior to elective cardiothoracic surgery and undergo breathing performance tests before and after the training period. A full thickness biopsy (approximately 6mm x 20 mm) from the right ventral costal diaphragm will be acquired as soon as the diaphragm is exposed during surgery. Additionally, a biopsy from the pectoralis major will be obtained and used as a non-exercised control muscle. Histological and RNA sequencing analyses will be performed to examine the mechanisms that contribute to neuromuscular adaptations to training.
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Cardiac surgery candidate
- Ability to complete pre-operative breathing exercises
Exclusion Criteria:
- Surgery is scheduled in less than 2 weeks
- New York Heart Association Class III or IV Cardiac Disease
- History of hemiparesis
- History of spinal cord injury
- History of progressive neuromuscular disease that may interfere with the ability to complete study interventions
- Previous cardiothoracic surgery within the last 12 weeks
- History of pneumonectomy
- History of lung surgery
- History of skeletal pathology (e.g. scoliosis) that may interfere with chest wall movements
- Routine usage of muscle relaxants, immunosuppressants, or corticosteroid medications within the past 30 days
- Forced expiratory volume 1 less than 40% of age-predicted value
- Presence of active malignancy
- Presence of any organ dysfunction that may limit ability to participate in seated respiratory exercises
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Inspiratory Muscle Training (IMT)
Pre-operative inspiratory muscle training
|
Inspiratory muscle training exercises, performed 5 times a week for 2-4 weeks prior to cardiac surgery.
|
Experimental: Relaxation Breathing (RLX)
Relaxation breathing exercises
|
Relaxation breathing exercises, performed 5 times a week for 2-4 weeks prior to cardiac surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximal inspiratory pressure
Time Frame: Post breathing exercise sessions (up to 4 weeks)
|
Maximal inspiratory pressure will be quantified in cm of water pressure.
|
Post breathing exercise sessions (up to 4 weeks)
|
Muscle fiber cross-sectional area and fiber type proportion.
Time Frame: Intra-operatively
|
Histology will be used to determine fiber type and cross-sectional area using primary antibodies for laminin and type-specific myosin heavy chain, followed by a triple immunofluorescence-conjugated secondary antibody labeling technique.
|
Intra-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peak expiratory flow
Time Frame: Post breathing exercise sessions (up to 4 weeks)
|
Spirometry will be used to measure peak expiratory flow during a voluntary cough maneuver.
It will be quantified in liters per second.
|
Post breathing exercise sessions (up to 4 weeks)
|
Time to extubation
Time Frame: Up to discharge from ICU
|
Time to extubation will be measured as hours of post-operative mechanical ventilation.
|
Up to discharge from ICU
|
Length of ICU stay
Time Frame: Up to 1 month
|
Length of ICU stay will be measured as hours spent in ICU after surgery.
|
Up to 1 month
|
Length of hospital stay
Time Frame: Up to 1 month
|
Length of hospital stay will be measured as hours spent in hospital after surgery.
|
Up to 1 month
|
Neuromuscular junction morphology
Time Frame: Intra-operatively
|
Histology will be used to assess neuromuscular junction number and morphology using immunofluorescent-labeled antibodies for synaptophysin and alpha bungarotoxin.
Neuromuscular junction image stacks will be visualized with confocal microscopy and morphology classified according to endplate area and area fractions of fragmented junctions, acetylcholine receptor-occupied endplate area, synaptophysin-occupied endplates, and abandoned endplates.
|
Intra-operatively
|
Muscle differential gene expression
Time Frame: Intra-operatively
|
RNA isolation will be performed using Tri Reagent and chloroform based manual method.
RNA will be quantified and RNA-Seq will be used to assess gene expression.
|
Intra-operatively
|
Physical Function
Time Frame: Post breathing exercise sessions (up to 4 weeks)
|
Physical function will be assessed with the Patient Reported Outcomes Measurement Information System Physical Function questionnaire.
Each answer corresponds to a number between 1 and 5.
|
Post breathing exercise sessions (up to 4 weeks)
|
Dyspnoea
Time Frame: Post breathing exercise sessions (up to 4 weeks)
|
Dyspnoea will be assessed with the Dyspnoea 12 Questionnaire.
Responses range from None to Severe.
|
Post breathing exercise sessions (up to 4 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thomas Beaver, MD, MPH, University of Florida
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB202001038
- OCR35362 (Other Identifier: UF OnCore)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mechanical Ventilation Complication
-
Hospital San Carlos, MadridFundación de Investigación Biomédica - Hospital Universitario de La PrincesaRecruitingMechanical Ventilation ComplicationSpain
-
Royal Brompton & Harefield NHS Foundation TrustRecruitingMechanical Ventilation ComplicationUnited Kingdom
-
Fundación de Investigación Biomédica - Hospital...Maquet Critical CareRecruitingMechanical Ventilation ComplicationSpain
-
Centre hospitalier de l'Université de Montréal...RecruitingMechanical Ventilation ComplicationCanada
-
Alexandria UniversityCompleted
-
Rush University Medical CenterCompletedMechanical Ventilation ComplicationUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...TerminatedMechanical Ventilation ComplicationNetherlands
-
Dr Cipto Mangunkusumo General HospitalActive, not recruitingMechanical Ventilation ComplicationIndonesia
-
Vietnam Military Medical UniversityVietnam National Cancer HospitalCompletedMechanical Ventilation ComplicationVietnam
-
Rabin Medical CenterBaxter Healthcare CorporationUnknown
Clinical Trials on Inspiratory Muscle Training
-
Elisabethinen HospitalUnknownStem Cell Transplantation | Inspiratory Muscle Training | Respiratory Muscle TrainingAustria
-
Dokuz Eylul UniversityDokuz Eylül University, Scientific Research Projects Coordination UnitCompleted
-
University of British ColumbiaNatural Sciences and Engineering Research Council, CanadaCompletedRespiratory Muscles | Breathing ExercisesCanada
-
Universidad Complutense de MadridColegio Profesional de Fisioterapeutas de la Comunidad de Madrid, Madrid,...CompletedQuality of Life | Covid19 | Respiratory Muscle Training | Respiratory Function Test | Psychosocial FactorSpain
-
King Saud UniversityCompleted
-
Universidade do PortoUnknownMuscle Weakness | Dyspnea | Reactive Airways Dysfunction Syndrome (Disorder)Portugal
-
Gazi UniversityCompletedAllogeneic Hematopoietic Stem Cell Transplantation
-
Gazi UniversityCompleted
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreUnknownChronic Kidney Disease